TIANAN MEDICARE (0383.HK)
- Previous Close
0.780 - Open
0.780 - Bid 0.740 x --
- Ask 0.840 x --
- Day's Range
0.780 - 0.780 - 52 Week Range
0.580 - 1.000 - Volume
1,600 - Avg. Volume
25,433 - Market Cap (intraday)
844.997M - Beta (5Y Monthly) 0.39
- PE Ratio (TTM)
26.00 - EPS (TTM)
0.030 - Earnings Date Mar 11, 2025
- Forward Dividend & Yield 0.02 (2.56%)
- Ex-Dividend Date May 23, 2025
- 1y Target Est
--
Tian An Medicare Limited, an investment holding company, primarily operates hospitals in the People's Republic of China and Hong Kong. It operates through Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments segments. The company also involved in property development of independent living units and project management of health campus with a focus on eldercare and retirement community including elderly nursing home, service apartments, independent living units and commercial area comprising shopping mall, retail shops, and club hall facilities. In addition, it develops and sells properties and lands; leases residential and office properties; and provides loan financial and healthcare services, as well as trading of securities listed in overseas exchange. The company was formerly known as China Medical & HealthCare Group Limited and changed its name to Tian An Medicare Limited in April 2024. Tian An Medicare Limited was incorporated in 1989 and is based in Wan Chai, Hong Kong. The company operates as a subsidiary of Tian An China Investments Company Limited.
www.tiananmedicare.com.hk2,626
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 0383.HK
View MorePerformance Overview: 0383.HK
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0383.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0383.HK
View MoreValuation Measures
Market Cap
844.99M
Enterprise Value
790.82M
Trailing P/E
29.43
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.52
Price/Book (mrq)
0.46
Enterprise Value/Revenue
0.49
Enterprise Value/EBITDA
4.31
Financial Highlights
Profitability and Income Statement
Profit Margin
1.77%
Return on Assets (ttm)
1.86%
Return on Equity (ttm)
2.23%
Revenue (ttm)
1.63B
Net Income Avi to Common (ttm)
28.77M
Diluted EPS (ttm)
0.030
Balance Sheet and Cash Flow
Total Cash (mrq)
886.19M
Total Debt/Equity (mrq)
44.13%
Levered Free Cash Flow (ttm)
-106.36M